Elanco Animal Health Incorporated
Market Cap
$12.52B
P/E Ratio
-53.57
EPS
$-0.47
Dividend Yield
0.00%
52-Week Range
$8.02 — $27.72
Volume
12.31M
Avg Volume
4.90M
Beta
1.89
P/E (TTM)
-53.57
Forward P/E
24.52
PEG Ratio
0.07
P/S (TTM)
2.46
P/B (TTM)
1.77
P/FCF
78.78
EV/EBITDA
75.98x
EV/Sales
—
ROE (TTM)
-0.04%
ROA (TTM)
-0.02%
ROIC
0.00%
Gross Margin
0.46%
Operating Margin
0.05%
Net Margin
-0.03%
Debt/Equity
0.61
Current Ratio
2.17
EPS Growth (YoY)
-1.09%
Revenue Growth (YoY)
+0.10%
EPS Growth (3Y)
-4.52%
EPS Growth (5Y)
-4.27%
Sales Growth (3Y)
-0.02%
Sales Growth (5Y)
+0.09%
EPS Est (This Year)
$1.03
EPS Est (Next Year)
$1.15
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$1.10
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $27.29(8.4% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
496.86M
Float
492.66M
Free Float %
99.16%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US
Exchange
NYSE
IPO Date
2018-09-20
Employees
9000
CEO
Jeffrey N. Simmons
Index Membership
—
Website
https://www.elanco.com
Elanco Animal Health Incorporated (ELAN) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NYSE. With a market capitalization of $12.52B, a P/E ratio of -53.57, ELAN is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ELAN against other stocks using dozens of fundamental and technical filters.
Elanco Animal Health Incorporated (ELAN) has a trailing twelve-month (TTM) P/E ratio of -53.57. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Elanco Animal Health Incorporated (ELAN) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Elanco Animal Health Incorporated (ELAN) has a market capitalization of $12.52 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on Elanco Animal Health Incorporated (ELAN) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $27.29 implies 8.4% upside from the current price.